Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-25-008751
Filing Date
2025-03-21
Accepted
2025-03-21 16:30:36
Documents
73
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K mbrx20241231_10k.htm   iXBRL 10-K 1927204
2 EXHIBIT 19 ex_791681.htm EX-19 57335
3 EXHIBIT 23.1 ex_728176.htm EX-23.1 2623
4 EXHIBIT 31.1 ex_728177.htm EX-31.1 12111
5 EXHIBIT 31.2 ex_728178.htm EX-31.2 12114
6 EXHIBIT 32.1 ex_728179.htm EX-32.1 5464
7 EXHIBIT 32.2 ex_728180.htm EX-32.2 5468
  Complete submission text file 0001437749-25-008751.txt   8424556

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20241231.xsd EX-101.SCH 77116
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbrx-20241231_cal.xml EX-101.CAL 55167
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20241231_def.xml EX-101.DEF 466718
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20241231_lab.xml EX-101.LAB 456098
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20241231_pre.xml EX-101.PRE 503549
76 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20241231_10k_htm.xml XML 1235691
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671997 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37758 | Film No.: 25760962
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)